Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
FWRG enters its November 3 earnings window in a peculiar position: short sellers have been quietly covering for weeks, options traders are growing less fearful, and yet the stock at $10.98 trades at nearly half the analyst consensus target of $19.30.
Short interest has fallen from a September peak of around 7.2 million shares to just under 6.5 million, a roughly 10% decline over the past month to 10.6% of the free float. The direction of travel matters here: bears have been retreating steadily since early September, not rushing for the exits but consistently trimming. Borrowing costs are low at 0.27% and have dropped 18% over the week, reflecting no urgency among new short sellers. Availability is extremely loose at over 1,100%, meaning there are roughly eleven shares available to borrow for every share currently shorted, so the structural conditions for a squeeze simply are not present. The ORTEX short score has drifted down from 55.4 at the end of September to 54.0 this week, a modest easing but consistent with the directional trend.
Options positioning has also shifted meaningfully in the bullish direction. The put/call ratio at 1.30 is running well below its 20-day average of 1.56, roughly 1.65 standard deviations below the mean, and far below readings above 5.0 that characterised the August and September selloff. That shift does not eliminate caution, the PCR is still above 1.0, meaning puts outnumber calls, but protective positioning has unwound substantially over the past six weeks. The 52-week PCR high of 6.01 puts the current reading in historical context: the crowd was far more defensive not long ago.
What makes the setup striking is the gap between where the stock trades and where analysts think it should be. Every analyst on the Street with a current rating carries a Buy or equivalent, and not one has gone to the sidelines. DA Davidson trimmed its target to $15 at the start of October, the most recent action, and even at that reduced level it implies roughly 37% upside from current prices. Guggenheim and Citigroup both kept Buy ratings after Q2 results in August while shading targets to $20. The mean target of $19.30 implies about 76% upside, a gap that reflects either a deeply pessimistic market or genuine uncertainty about whether First Watch can execute. The bull case centres on improving traffic, a digital marketing pivot, unaided brand awareness up more than 50% since early 2025, and the long-term potential of trimming new unit openings to reduce cannibalization and push four-wall margins toward 20%. The bear case is more prosaic: thin margins, a commodity basket dominated by eggs, bacon, avocado and coffee, intense competition from better-resourced chains, and a third of all locations concentrated in Florida and Texas.
Valuation offers little comfort to either side in the near term. The stock trades at a trailing PE near 50 and an EV/EBITDA of just under 11. The PE has edged marginally higher over the past month as the stock has recovered slightly from its October lows, but the EV/EBITDA multiple has been broadly flat. Factor scores paint a cautious picture: EPS momentum over the past 30 and 90 days ranks in the 12th and 28th percentiles respectively, and the forward earnings growth score is in the 8th percentile. The ORTEX sector score sits at the 50th percentile, squarely in the middle.
Among correlated peers, PTLO was the standout this week, up nearly 15%, while CAVA fell 1.4% and KRUS dropped 2.4%. First Watch's 3.9% gain on the week is solid but does not keep pace with the best performers in the group, and the stock remains down roughly 11% over the past month, a period that saw short interest at its heaviest.
With Q3 results due November 3, the next four weeks will test whether the gradual short covering and the easing of defensive options positioning mark a genuine sentiment shift, or simply reflect positioning washout ahead of a print that still has to prove same-store sales are tracking within the guided 1% to 3% range.
See the live data behind this article on ORTEX.
Open FWRG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.